enGene Therapeutics Inc (ENGN) vs Tiziana Life Sciences Ltd (TLSA)

enGene Therapeutics Inc and Tiziana Life Sciences Ltd are both Biotechnology companies. enGene Therapeutics Inc and Tiziana Life Sciences Ltd are of similar size ($131.1M and $128.7M). Across the 9 metrics below, Tiziana Life Sciences Ltd leads on 8 and enGene Therapeutics Inc on 1.

Valuation

Metric ENGN TLSA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.59 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.76 0.04 0.74
EV/Sales n/m n/m 10.73
Earnings yield (105.41%) (51.86%) (28.84%)
Free cash flow yield (76.09%) 0.00% (23.03%)

Profitability

Metric ENGN TLSA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (60.50%) 0.00% (57.72%)
Return on assets (48.84%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENGN TLSA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (56.85%) (45.45%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENGN TLSA Biotechnology median
Debt to equity 0.11 0.00 0.00
Current ratio 10.21 0.76 4.73
Net debt to EBITDA 1.42 0.19 0.96

Dividend

Metric ENGN TLSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ENGN TLSA Biotechnology median
Market cap 128.67m 131.11m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack